NL7013068A
(fr)
|
1969-09-17 |
1971-03-19 |
|
|
US4537889A
(en)
|
1982-12-27 |
1985-08-27 |
Eli Lilly And Company |
Inotropic agents
|
US4614810A
(en)
|
1984-09-24 |
1986-09-30 |
Pennwalt Corporation |
4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
|
US4625040A
(en)
|
1984-09-24 |
1986-11-25 |
Pennwalt Corporation |
N-(phenyl) or N-(phenylcyclopropyl)-2,5-dihydro-2-oxo-4[(substituted phenyl)amino]-3-furancarboxamide derivatives
|
FR2607813B1
(fr)
|
1986-12-05 |
1989-03-31 |
Montpellier I Universite |
Alkylamino-8 imidazo (1,2-a) pyrazines et derives, leur preparation et leur application en therapeutique
|
JPH032778Y2
(fr)
|
1986-12-15 |
1991-01-24 |
|
|
AU622330B2
(en)
|
1989-06-23 |
1992-04-02 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
|
JP2844351B2
(ja)
|
1989-07-13 |
1999-01-06 |
株式会社科薬 |
安定なポリミキシン系抗生物質水性溶液
|
IL96432A0
(en)
|
1989-11-30 |
1991-08-16 |
Schering Ag |
Pesticidal compositions containing pyridine derivatives and novel pyridine derivatives
|
FR2662163A1
(fr)
|
1990-05-16 |
1991-11-22 |
Lipha |
Nouvelles 8-amino-1,2,4-triazolo(4,3-a) pyrazines, procedes de preparation et medicaments les contenant.
|
DE69323883T2
(de)
|
1992-06-17 |
1999-07-22 |
Upjohn Co |
Pyrridino-, pyrrolidino- und azepino-substituierte oxime als antiatherosklerosemittel und antihypercholesterolemiemittel
|
JP2923139B2
(ja)
|
1992-10-05 |
1999-07-26 |
三井化学株式会社 |
製 剤
|
DE4327027A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Imidazoazine
|
FR2711993B1
(fr)
|
1993-11-05 |
1995-12-01 |
Rhone Poulenc Rorer Sa |
Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation.
|
US5932223A
(en)
|
1996-09-26 |
1999-08-03 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
WO1999024434A1
(fr)
|
1997-11-11 |
1999-05-20 |
Ono Pharmaceutical Co., Ltd. |
Composes de pyrazine condenses
|
JP2000319278A
(ja)
|
1999-05-11 |
2000-11-21 |
Ono Pharmaceut Co Ltd |
縮合ピラジン化合物およびその化合物を有効成分とする薬剤
|
JP2000319277A
(ja)
|
1999-05-11 |
2000-11-21 |
Ono Pharmaceut Co Ltd |
縮合ピラジン化合物およびその化合物を有効成分とする薬剤
|
JP4032566B2
(ja)
|
1999-06-21 |
2008-01-16 |
東レ株式会社 |
発光素子
|
JP4041624B2
(ja)
|
1999-07-21 |
2008-01-30 |
三井化学株式会社 |
有機電界発光素子
|
JP2001057292A
(ja)
|
1999-08-20 |
2001-02-27 |
Toray Ind Inc |
発光素子
|
WO2001022791A2
(fr)
|
1999-09-28 |
2001-04-05 |
Panacea Biotec Limited |
Compositions a liberation regulee contenant de la nimesulide
|
SE9903611D0
(sv)
|
1999-10-06 |
1999-10-06 |
Astra Ab |
Novel compounds III
|
DE19948434A1
(de)
|
1999-10-08 |
2001-06-07 |
Gruenenthal Gmbh |
Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
|
JP4409680B2
(ja)
|
1999-10-18 |
2010-02-03 |
株式会社ヤクルト本社 |
三環性縮合イミダゾール誘導体
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
CN1173975C
(zh)
|
2000-04-27 |
2004-11-03 |
山之内制药株式会社 |
咪唑并吡啶衍生物
|
CN1321628C
(zh)
|
2000-06-28 |
2007-06-20 |
史密斯克莱·比奇曼公司 |
湿磨方法
|
AR029538A1
(es)
|
2000-07-06 |
2003-07-02 |
Wyeth Corp |
Composiciones farmaceuticas de agentes estrogenicos
|
US6589952B2
(en)
|
2000-07-14 |
2003-07-08 |
Bristol-Myers Squibb Pharma Company |
Imidazo[1,2-a]pyrazines for the treatment of neurological disorders
|
DE10050663A1
(de)
|
2000-10-13 |
2002-04-18 |
Gruenenthal Gmbh |
Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
|
AU2001295992A1
(en)
|
2000-10-24 |
2002-05-06 |
Sankyo Company Limited |
Imidazopyridine derivatives
|
JP2002205992A
(ja)
|
2000-11-08 |
2002-07-23 |
Takeda Chem Ind Ltd |
二環式トリアゾロン誘導体およびそれを含有する除草剤
|
AU2002212530B2
(en)
|
2000-11-10 |
2006-08-17 |
Merck Sharp & Dohme Limited |
Imidazo-triazine derivatives as ligands for GABA receptors
|
WO2002048146A2
(fr)
|
2000-12-13 |
2002-06-20 |
Basf Aktiengesellschaft |
Utilisation d'imidazoazines substituees, nouvelles imidazoazines, procede permettant de les produire et agents les contenant
|
EP1217000A1
(fr)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibiteurs du factor Xa et factor VIIa
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
US6951848B2
(en)
|
2001-03-12 |
2005-10-04 |
Millennium Pharmaceuticals, Inc., |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
IL159811A0
(en)
|
2001-07-13 |
2004-06-20 |
Neurogen Corp |
Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
|
US6921762B2
(en)
*
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
US20050113283A1
(en)
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
EP1513522A2
(fr)
|
2002-01-18 |
2005-03-16 |
Sri International |
Procedes pour traiter des pathologies associees a un recepteur d'edg
|
WO2004017950A2
(fr)
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Inhibiteurs de phosphatidylinositol 3,5-biphosphate en tant qu'agents antiviraux
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
EP1576150A4
(fr)
|
2002-10-16 |
2006-05-03 |
Univ Texas |
Procedes et compositions pour augmenter l'efficacite de substances actives d'un point de vue biologique
|
AU2003297431A1
(en)
|
2002-12-20 |
2004-07-22 |
Pharmacia Corporation |
Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
|
US7160885B2
(en)
|
2003-02-10 |
2007-01-09 |
Cgi Pharmaceuticals, Inc. |
Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity
|
US7186832B2
(en)
|
2003-02-20 |
2007-03-06 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
US7157460B2
(en)
|
2003-02-20 |
2007-01-02 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
GB0303910D0
(en)
|
2003-02-20 |
2003-03-26 |
Merck Sharp & Dohme |
Therapeutic agents
|
TWI344955B
(en)
|
2003-03-14 |
2011-07-11 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
EP1615647B1
(fr)
|
2003-04-11 |
2010-01-20 |
High Point Pharmaceuticals, LLC |
Utilisation pharmaceutique de 1,2,4-triazoles fusionnes
|
WO2004089416A2
(fr)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Polytherapie utilisant un inhibiteur de type 1 de la 11beta-hydroxysteroide deshydrogenase et un agent hypotenseur dans le traitement du syndrome metabolique et des troubles et maladies associes
|
EP1622616B1
(fr)
|
2003-04-24 |
2011-06-15 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de l'activite akt
|
SE0301653D0
(sv)
|
2003-06-05 |
2003-06-05 |
Astrazeneca Ab |
Novel compounds
|
EP2287165A3
(fr)
|
2003-07-14 |
2011-06-22 |
Arena Pharmaceuticals, Inc. |
Dérivés d'hétéroaryle et aryle fusionné en tant que modulateurs du métabolisme et prophylaxie et traitement des troubles associés
|
US7538120B2
(en)
|
2003-09-03 |
2009-05-26 |
Array Biopharma Inc. |
Method of treating inflammatory diseases
|
AU2004271741A1
(en)
|
2003-09-12 |
2005-03-24 |
Laboratoires Serono Sa |
Sulfonamide derivatives for the treatment of diabetes
|
JP2005089352A
(ja)
|
2003-09-16 |
2005-04-07 |
Kissei Pharmaceut Co Ltd |
新規なイミダゾ[1,5−a]ピラジン誘導体、それを含有する医薬組成物およびそれらの用途
|
WO2005035532A1
(fr)
|
2003-10-10 |
2005-04-21 |
Pfizer Products Inc. |
2h-[1,2,4]triazolo[4,3-a]pyrazines substituees en tant qu'inhibiteurs de la gsk-3
|
US7419978B2
(en)
|
2003-10-22 |
2008-09-02 |
Bristol-Myers Squibb Company |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
|
EP1677791A4
(fr)
|
2003-10-31 |
2007-08-15 |
Takeda Pharmaceutical |
Composes heterocycliques accoles contenant de l'azote
|
US20080249154A1
(en)
|
2003-12-26 |
2008-10-09 |
Ono Pharmaceutical Co., Ltd. |
Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
|
EP1717238A4
(fr)
|
2004-02-16 |
2008-03-05 |
Daiichi Seiyaku Co |
Composes heterocycliques fongicides
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
ATE516019T1
(de)
|
2004-05-11 |
2011-07-15 |
Egalet Ltd |
Quellbare dosierform mit gellan-gummit
|
TW200612918A
(en)
|
2004-07-29 |
2006-05-01 |
Threshold Pharmaceuticals Inc |
Lonidamine analogs
|
EP1781655A2
(fr)
|
2004-08-18 |
2007-05-09 |
Pharmacia & Upjohn Company LLC |
Nouveaux composes de triazolopyridine pour le traitement d'inflammation
|
WO2006026703A2
(fr)
*
|
2004-09-02 |
2006-03-09 |
Smithkline Beecham Corporation |
Composes chimiques
|
MX2007004179A
(es)
|
2004-10-07 |
2007-06-07 |
Warner Lambert Co |
Derivados de triazolpiridina como agentes antibacterianos.
|
KR20070086595A
(ko)
|
2004-11-22 |
2007-08-27 |
쓰레솔드 파마슈티컬스, 인코포레이티드 |
튜불린 결합 항암제 및 이의 전구약물
|
ATE443063T1
(de)
|
2004-12-01 |
2009-10-15 |
Merck Serono Sa |
Ä1,2,4ütriazoloä4,3-aüpyridin-derivative zur behandlung hyperproliferativer erkrankungen
|
WO2006073938A2
(fr)
|
2004-12-30 |
2006-07-13 |
East Carolina University |
Procede de synthese de composes de indolizine 3-substituee et de benzoindolizine
|
US7456289B2
(en)
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
BRPI0607456A2
(pt)
|
2005-02-22 |
2009-09-08 |
Pfizer |
derivados de oxindol como agonistas do receptor 5ht4
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
CA2606288A1
(fr)
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Antagonistes cb1 heteroaryle substitue
|
ATE480239T1
(de)
|
2005-06-09 |
2010-09-15 |
Oncalis Ag |
Angiogeneseinhibitoren
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
US7452892B2
(en)
|
2005-06-17 |
2008-11-18 |
Bristol-Myers Squibb Company |
Triazolopyrimidine cannabinoid receptor 1 antagonists
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
US7572808B2
(en)
|
2005-06-17 |
2009-08-11 |
Bristol-Myers Squibb Company |
Triazolopyridine cannabinoid receptor 1 antagonists
|
EP1928237A4
(fr)
|
2005-09-02 |
2011-03-09 |
Abbott Lab |
Nouveaux heterocycles a base imidazo
|
CN101300233A
(zh)
*
|
2005-09-09 |
2008-11-05 |
先灵公司 |
氮杂稠合的细胞周期蛋白依赖性激酶抑制剂
|
RU2008122967A
(ru)
|
2005-11-10 |
2009-12-20 |
Шеринг Корпорейшн (US) |
Имидазопиразины в качестве ингибиторов протеинкиназ
|
EA017290B1
(ru)
|
2005-11-28 |
2012-11-30 |
Домейн Раша Инвестментс Лимитед |
Композиции на основе ганаксолона
|
CA2633536A1
(fr)
|
2005-12-27 |
2007-07-05 |
F. Hoffmann-La Roche Ag |
Derives aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine
|
WO2007074491A1
(fr)
|
2005-12-28 |
2007-07-05 |
Universita Degli Studi Di Siena |
Derives d’amide heterotricycliques en tant que ligands du recepteur de neurokinine-1 (nk1)
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
EP2004643A1
(fr)
|
2006-03-31 |
2008-12-24 |
Novartis AG |
Composés organiques
|
US20090175852A1
(en)
|
2006-06-06 |
2009-07-09 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
TW200808802A
(en)
|
2006-06-06 |
2008-02-16 |
Schering Corp |
Imidazopyrazines as protein kinase inhibitors
|
US8115000B2
(en)
|
2006-06-22 |
2012-02-14 |
Mallinckrodt Llc |
Pyrazine derivatives and uses thereof in renal monitoring
|
US9216963B2
(en)
|
2006-06-22 |
2015-12-22 |
Medibeacon Inc. |
Pyrazine derivatives with extended conjugation and methods of using the same in optical applications
|
AU2007269830A1
(en)
|
2006-06-29 |
2008-01-10 |
Schering Corporation |
Substituted bicyclic and tricyclic thrombin receptor antagonists
|
WO2008005423A1
(fr)
|
2006-07-03 |
2008-01-10 |
Cambrex Charles City, Inc. |
Méthode améliorée de fabrication de sufentanil
|
WO2008005908A2
(fr)
|
2006-07-07 |
2008-01-10 |
Forest Laboratories Holdings Limited |
Dérivés de pyridoïmidazole
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US20080021217A1
(en)
|
2006-07-20 |
2008-01-24 |
Allen Borchardt |
Heterocyclic inhibitors of rho kinase
|
US7563797B2
(en)
|
2006-08-28 |
2009-07-21 |
Forest Laboratories Holding Limited |
Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
|
DE102006041292A1
(de)
|
2006-09-01 |
2008-03-06 |
Henkel Kgaa |
Wasserstoffperoxid-Aktivierung mit N-Heterocyclen
|
WO2008037607A1
(fr)
|
2006-09-25 |
2008-04-03 |
Basf Se |
Composés hétérocycliques à teneur en groupe carbonyle et leur utilisation pour lutter contre des champignons phytopathogènes
|
ATE542818T1
(de)
|
2006-10-11 |
2012-02-15 |
Amgen Inc |
Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung
|
WO2008063910A2
(fr)
|
2006-11-08 |
2008-05-29 |
Novavax, Inc. |
Procédé pour préparer des formes de dosage solides de compositions pharmaceutiques à plusieurs phases
|
CA2668689C
(fr)
|
2006-11-08 |
2015-12-29 |
Neurocrine Biosciences Inc. |
Composes 3-isobutyl-9, 10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-2-ol substitues et procedes associes
|
WO2008056176A1
(fr)
|
2006-11-10 |
2008-05-15 |
Scottish Biomedical Limited |
Pyrazolopyrimidines utiles comme inhibiteurs de la phosphodiestérase
|
JP5572388B2
(ja)
|
2006-11-22 |
2014-08-13 |
インサイト・コーポレイション |
キナーゼ阻害剤としてのイミダゾトリアジンおよびイミダゾピリミジン
|
ATE495743T1
(de)
|
2006-12-01 |
2011-02-15 |
Galapagos Nv |
Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
|
WO2008079404A2
(fr)
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Compositions pharmaceutiques pour le traitement de la maladie de parkinson et de troubles apparentés
|
JP5612860B2
(ja)
|
2007-03-09 |
2014-10-22 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としてのイミダゾ[1,5−a]ピリジン誘導体
|
DE102007012645A1
(de)
|
2007-03-16 |
2008-09-18 |
Bayer Healthcare Ag |
Substituierte Imidazo- und Triazolopyrimidine
|
EP1972628A1
(fr)
|
2007-03-21 |
2008-09-24 |
Schwarz Pharma Ag |
Indolizines et leurs dérivés aza analogues en tant que composés actifs du SNC
|
JP2010523725A
(ja)
|
2007-04-16 |
2010-07-15 |
レオ ファーマ アクティーゼルスカブ |
皮膚疾患処置用ホスホジエステラーゼ阻害剤としてのトリアゾロピリジン
|
US8546394B2
(en)
*
|
2007-04-17 |
2013-10-01 |
Bristol-Myers Squibb Company |
Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
|
PT2155747E
(pt)
|
2007-05-10 |
2012-12-19 |
Ge Healthcare Ltd |
Imidazol(1,2-a)piridinas e compostos relacionados com actividade nos receptores de canabinóides cb2
|
ES2648037T3
(es)
|
2007-05-21 |
2017-12-28 |
Toray Industries, Inc. |
Preparación oral que comprende un ácido orgánico específico y método para mejorar la propiedad de disolución y la estabilidad química de la preparación oral
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
KR20100032886A
(ko)
|
2007-06-08 |
2010-03-26 |
아보트 러보러터리즈 |
키나제 억제제로서의 5-헤테로아릴 치환된 인다졸
|
AR066958A1
(es)
|
2007-06-14 |
2009-09-23 |
Schering Corp |
Imidazopirazinas como inhibidores de proteina quinasa
|
CL2008001839A1
(es)
|
2007-06-21 |
2009-01-16 |
Incyte Holdings Corp |
Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
|
US20090004281A1
(en)
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
EA201000130A1
(ru)
|
2007-07-18 |
2010-08-30 |
Новартис Аг |
Бициклические гетероарильные соединения и их применение в качестве ингибиторов киназы
|
CA2694218A1
(fr)
|
2007-07-31 |
2009-02-05 |
Schering Corporation |
Combinaison d'agent antimitotique et d'inhibiteur de l'aurora kinase comme traitement anti-cancer
|
WO2009017954A1
(fr)
|
2007-08-01 |
2009-02-05 |
Phenomix Corporation |
Inhibiteurs de kinase jak2
|
JP2010535773A
(ja)
|
2007-08-10 |
2010-11-25 |
グラクソスミスクライン エルエルシー |
ウイルス感染を治療するための窒素含有二環式化学物質
|
US20090047336A1
(en)
|
2007-08-17 |
2009-02-19 |
Hong Kong Baptist University |
novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation
|
FR2920090A1
(fr)
|
2007-08-24 |
2009-02-27 |
Oreal |
Composition tinctoriale comprenant une base d'oxydation aminopyrazolopyridine particuliere, un coupleur et un tensioactif particulier.
|
FR2920091A1
(fr)
|
2007-08-24 |
2009-02-27 |
Oreal |
Composition tinctoriale comprenant une base d'oxydation aminopyrazolopyridine, un coupleur et un polyol particulier.
|
KR20090022616A
(ko)
|
2007-08-31 |
2009-03-04 |
한올제약주식회사 |
베실산클로피도그렐 함유 경구투여용 약제
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
GB0719803D0
(en)
|
2007-10-10 |
2007-11-21 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
CN101861321B
(zh)
|
2007-10-11 |
2013-02-06 |
阿斯利康(瑞典)有限公司 |
作为蛋白激酶b抑制剂的吡咯并[2,3-d]嘧啶衍生物
|
KR20170021904A
(ko)
|
2007-10-12 |
2017-02-28 |
노파르티스 아게 |
스핑고신 1 포스페이트 (s1p) 수용체 조절제를 포함하는 조성물
|
AU2008343062B2
(en)
|
2007-12-19 |
2013-03-07 |
Genentech, Inc. |
8-Anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
|
EP2231661A1
(fr)
|
2007-12-19 |
2010-09-29 |
Amgen, Inc. |
Inhibiteurs de la pi3 kinase
|
KR100988233B1
(ko)
|
2007-12-26 |
2010-10-18 |
한미홀딩스 주식회사 |
클로피도그렐 1,5-나프탈렌 다이술폰산 염 또는 이의수화물의 약학 조성물 및 제제
|
SI2288610T1
(sl)
|
2008-03-11 |
2016-11-30 |
Incyte Holdings Corporation |
Derivati azetidina in ciklobutana kot inhibitorji jak
|
KR20150140418A
(ko)
|
2008-03-12 |
2015-12-15 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로사이클 융합 감마-카볼라인 고체
|
WO2009114180A1
(fr)
|
2008-03-13 |
2009-09-17 |
The General Hospital Corporation |
Inhibiteurs de la voie de signalisation bmp
|
US8637542B2
(en)
*
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
WO2009128520A1
(fr)
|
2008-04-18 |
2009-10-22 |
塩野義製薬株式会社 |
Composé hétérocyclique présentant une activité inhibitrice sur p13k
|
DE102008023801A1
(de)
|
2008-05-15 |
2009-11-19 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine
|
US8349210B2
(en)
|
2008-06-27 |
2013-01-08 |
Transitions Optical, Inc. |
Mesogenic stabilizers
|
WO2010010184A1
(fr)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
[1, 2, 4]triazolo[1, 5-a]pyridines utilisées comme inhibiteurs de jak
|
WO2010010189A1
(fr)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Nouveaux composés utiles pour le traitement de maladies dégénératives et inflammatoires
|
WO2010010187A1
(fr)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Nouveaux composés utiles pour le traitement de maladies dégénératives et inflammatoires
|
WO2010010188A1
(fr)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Nouveaux composés utiles pour le traitement de maladies dégénératives et inflammatoires
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
TR200806298A2
(tr)
|
2008-08-22 |
2010-03-22 |
Bi̇lgi̇ç Mahmut |
Farmasötik formülasyon
|
US20120021519A1
(en)
|
2008-09-19 |
2012-01-26 |
Presidents And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
JP2010070503A
(ja)
|
2008-09-19 |
2010-04-02 |
Daiichi Sankyo Co Ltd |
抗真菌作用2−アミノトリアゾロピリジン誘導体
|
CA2738429C
(fr)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Inhibiteurs heterocycliques de kinases
|
EP2361242B1
(fr)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Inhibiteurs de l'oxydase et leur utilisation
|
WO2010048149A2
(fr)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Modulateurs hétérocycliques de gpr119 pour le traitement d'une maladie
|
ES2403633T3
(es)
|
2008-12-04 |
2013-05-20 |
Proximagen Limited |
Compuestos de imidazopiridina
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
WO2010084160A1
(fr)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Dérivés de phénylcyclopropylamine et leur utilisation médicale
|
WO2010090991A1
(fr)
|
2009-02-04 |
2010-08-12 |
Supernus Pharmaceuticals, Inc. |
Formulations de desvenlafaxine
|
US8598163B2
(en)
|
2009-02-04 |
2013-12-03 |
Vitae Pharmaceuticals, Inc. |
Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders
|
TR200900879A2
(tr)
|
2009-02-05 |
2010-08-23 |
Bi̇lgi̇ç Mahmut |
Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
|
TR200900878A2
(tr)
|
2009-02-05 |
2010-08-23 |
Bi̇lgi̇ç Mahmut |
Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
|
CN102361872B
(zh)
|
2009-02-13 |
2014-12-03 |
拜耳知识产权有限责任公司 |
作为akt抑制剂的稠合嘧啶
|
WO2010104306A2
(fr)
|
2009-03-07 |
2010-09-16 |
주식회사 메디젠텍 |
Compositions pharmaceutiques pour traiter ou prévenir des maladies causées par la translocation de gsk3 du noyau cellulaire au cytoplasme, contenant des composés inhibant la translocation de gsk3 du noyau cellulaire au cytoplasme
|
WO2010107404A1
(fr)
|
2009-03-16 |
2010-09-23 |
Mahmut Bilgic |
Combinaisons pharmaceutiques stables
|
TW201035078A
(en)
|
2009-03-20 |
2010-10-01 |
Incyte Corp |
Substituted heterocyclic compounds
|
CA2755132C
(fr)
|
2009-03-31 |
2018-02-13 |
Kissei Pharmaceutical Co., Ltd. |
Derive d'indolizine et son utilisation pour des objectifs medicaux
|
CA2756759C
(fr)
|
2009-04-16 |
2017-11-07 |
Joaquin Pastor Fernandez |
Imidazopyrazines pour une utilisation en tant qu'inhibiteurs de kinase
|
TWI461426B
(zh)
|
2009-05-27 |
2014-11-21 |
Merck Sharp & Dohme |
(二氫)咪唑並異〔5,1-a〕喹啉類
|
CA2764808A1
(fr)
|
2009-06-10 |
2010-12-16 |
Sunovion Pharmaceuticals Inc. |
Agonistes inverses et antagonistes de l'histamine h3 et methodes d'utilisation associees
|
JP5732453B2
(ja)
|
2009-06-25 |
2015-06-10 |
アルカーメス ファーマ アイルランド リミテッド |
Nh酸性化合物のプロドラッグ
|
JP5819831B2
(ja)
|
2009-08-17 |
2015-11-24 |
インテリカイン, エルエルシー |
複素環式化合物およびそれらの使用
|
WO2011022489A2
(fr)
|
2009-08-18 |
2011-02-24 |
The Johns Hopkins University |
Composés (bis)urée et (bis)thiourée en tant que modulateurs épigéniques de la déméthylase 1 spécifique à la lysine et méthodes de traitement de troubles
|
WO2011033265A1
(fr)
|
2009-09-18 |
2011-03-24 |
Almac Discovery Limited |
Composés pharmaceutiques
|
US8859555B2
(en)
|
2009-09-25 |
2014-10-14 |
Oryzon Genomics S.A. |
Lysine Specific Demethylase-1 inhibitors and their use
|
EP2486002B1
(fr)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Acétamides d'hétéroaryl- et aryl-cyclopropylamine substitués et leur utilisation
|
WO2011050245A1
(fr)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Hétéroaryles bicycliques formant inhibiteurs de la kinase
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
US8614315B2
(en)
|
2009-12-25 |
2013-12-24 |
Mahmut Bilgic |
Cefdinir and cefixime formulations and uses thereof
|
WO2011089400A1
(fr)
|
2010-01-22 |
2011-07-28 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Inhibiteurs de la pi3 kinase
|
US20130085133A1
(en)
|
2010-02-08 |
2013-04-04 |
Sourthern Research Institute Office of Commercialization and Intellectual Prop. |
Anti-viral treatment and assay to screenfor anti-viral agent
|
WO2011106574A2
(fr)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibiteurs destinés à une utilisation antivirale
|
WO2011106106A2
(fr)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibiteurs de lysine déméthylase pour lutter contre les maladies et troubles associés à l'hepadnaviridae
|
TW201200518A
(en)
|
2010-03-10 |
2012-01-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
SG184073A1
(en)
|
2010-03-18 |
2012-10-30 |
Pasteur Institut Korea |
Anti-infective compounds
|
EP2547680B1
(fr)
|
2010-03-18 |
2015-08-05 |
Bayer Intellectual Property GmbH |
Imidazopyrazines
|
PL2552920T3
(pl)
|
2010-04-02 |
2017-08-31 |
Ogeda Sa |
Nowe wybiórcze związki antagonistów receptora NK-3, farmaceutyczne kompozycje i sposoby do zastosowania w zaburzeniach pośredniczonych przez receptory NK-3
|
CA2796726C
(fr)
|
2010-04-19 |
2021-02-16 |
Oryzon Genomics S.A. |
Inhibiteurs de la demethylase-1 specifiques de la lysine, et leur utilisation
|
PL2560949T3
(pl)
|
2010-04-20 |
2017-01-31 |
Università Degli Studi Di Roma "La Sapienza" |
Pochodne tranylocyprominy jako inhibitory demetylazy histonowej LSD1 i/lub LSD2
|
MX2012012145A
(es)
*
|
2010-04-28 |
2012-11-21 |
Daiichi Sankyo Co Ltd |
Compuestos [5, 6] heterociclico.
|
US20130131057A1
(en)
|
2010-05-13 |
2013-05-23 |
Centro Nacional De Investigaciones Oncologicas (Cnio |
New bicyclic compounds as pi3-k and mtor inhibitors
|
EA201291236A1
(ru)
|
2010-05-13 |
2013-11-29 |
Эмджен Инк. |
Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10
|
CN102247321A
(zh)
|
2010-05-20 |
2011-11-23 |
上海亚盛医药科技有限公司 |
一种阿朴棉子酚酮自乳化药物传递***及其制备方法
|
WO2011149438A1
(fr)
|
2010-05-28 |
2011-12-01 |
Mahmut Bilgic |
Combinaison d'agents antihypertenseurs
|
CN102295642B
(zh)
*
|
2010-06-25 |
2016-04-06 |
中国人民解放军军事医学科学院毒物药物研究所 |
2-芳基咪唑并[1,2-a]吡啶-3-乙酰胺衍生物、其制备方法及用途
|
CN103096977B
(zh)
|
2010-07-02 |
2017-02-15 |
吉利德科学公司 |
作为离子通道调节剂的稠杂环化合物
|
ES2552841T3
(es)
|
2010-07-12 |
2015-12-02 |
Bayer Intellectual Property Gmbh |
Imidazo[1,2-a]pirimidinas y -piridinas sustituidas
|
WO2012009475A1
(fr)
|
2010-07-14 |
2012-01-19 |
Oregon Health & Science University |
Méthodes de traitement du cancer par inhibition de la déméthylase 1 spécifique de la lysine
|
CN101987082B
(zh)
|
2010-07-16 |
2013-04-03 |
钟术光 |
固体制剂及其制备方法
|
CN101987081B
(zh)
|
2010-07-16 |
2012-08-08 |
钟术光 |
一种控释制剂
|
WO2012016133A2
(fr)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Inhibiteurs de la ros1 kinase pour le traitement de glioblastome et d'autres cancers déficients en p53
|
RS57331B1
(sr)
|
2010-07-29 |
2018-08-31 |
Oryzon Genomics Sa |
Inhibitori demetilaze za lsd1 zasnovani na arilciklopropilaminu i njihova medicinska upotreba
|
US9006449B2
(en)
|
2010-07-29 |
2015-04-14 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as LSD1 inhibitors
|
CN102397552B
(zh)
|
2010-09-10 |
2016-06-08 |
广州自远生物科技有限公司 |
一种含喹诺酮类的药物复合制剂及其制备方法和应用
|
WO2012034116A2
(fr)
|
2010-09-10 |
2012-03-15 |
The Johns Hopkins University |
Petites molécules à titre de modulateurs épigénétiques de la déméthylase 1 spécifique de la lysine et méthodes de traitement de troubles
|
WO2012043638A1
(fr)
|
2010-09-29 |
2012-04-05 |
キッセイ薬品工業株式会社 |
Dérivé d'(aza)indolizine et son utilisation pharmaceutique
|
US20130303545A1
(en)
|
2010-09-30 |
2013-11-14 |
Tamara Maes |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
US20120108500A1
(en)
|
2010-10-07 |
2012-05-03 |
Naoki Sakane |
Compositions and Methods for Modulating Immunodeficiency Virus Transcription
|
EP2629614B1
(fr)
|
2010-10-18 |
2014-09-17 |
E.I. Du Pont De Nemours And Company |
Sulfamides nématicides
|
WO2012052745A1
(fr)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinaisons d'inhibiteurs de pi3k avec un second agent antitumoral
|
PT2630146T
(pt)
|
2010-10-21 |
2020-07-20 |
Medivation Tech Llc |
Sal tosilato de (8s,9r)-5-fluoro-8-(4-fluorofenil)-9-(1-metil-1h-1,2,4-triazol-5-il)-8,9-di-hidro-2h-pirido[4,3,2-de]ftalazin-3(7h)-ona cristalino
|
EP2444084A1
(fr)
|
2010-10-21 |
2012-04-25 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Utilisation d'inhibiteurs de PI3K pour le traitement de l'obésité
|
WO2012071469A2
(fr)
|
2010-11-23 |
2012-05-31 |
Nevada Cancer Institute |
Inhibiteurs d'histone déméthylase et utilisations de ceux-ci pour le traitement de cancer
|
WO2012072713A2
(fr)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Inhibiteurs de la déméthylase spécifique de la lysine pour des maladies et troubles liés aux flaviviridés
|
CN103298460B
(zh)
|
2010-12-14 |
2016-06-01 |
电泳有限公司 |
酪蛋白激酶1δ(CK1δ)抑制剂
|
UY33805A
(es)
|
2010-12-17 |
2012-07-31 |
Boehringer Ingelheim Int |
?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?.
|
WO2012080234A1
(fr)
|
2010-12-17 |
2012-06-21 |
Bayer Pharma Aktiengesellschaft |
6-imidazopyrazines substituées pour l'utilisation en tant qu'inhibiteurs de mps-1 et de tkk dans le traitement de troubles d'hyperprolifération
|
EP2651945A1
(fr)
|
2010-12-17 |
2013-10-23 |
Bayer Intellectual Property GmbH |
Imidazopyrazines 6-substituées pour utilisation en tant qu'inhibiteurs de mps-1 et tkk dans le traitement de troubles hyperprolifératifs
|
EP2651946B1
(fr)
|
2010-12-17 |
2015-05-27 |
Bayer Intellectual Property GmbH |
Imidazopyrazines 2-substituées pour l'utilisation en tant qu'inhibiteurs de mps-1 et de tkk dans le traitement de troubles d'hyperprolifération
|
US20140187548A1
(en)
|
2010-12-17 |
2014-07-03 |
Bayer Intellectual Property Gmbh |
6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
TWI617559B
(zh)
|
2010-12-22 |
2018-03-11 |
江蘇恆瑞醫藥股份有限公司 |
2-芳基咪唑并[1,2-b]嗒.2-苯基咪唑并[1,2-a]吡啶,和2-苯基咪唑并[1,2-a]吡衍生物
|
US8987271B2
(en)
|
2010-12-22 |
2015-03-24 |
Eutropics Pharmaceuticals, Inc. |
2,2′-biphenazine compounds and methods useful for treating disease
|
JP2014504604A
(ja)
|
2011-01-21 |
2014-02-24 |
ザ ジェネラル ホスピタル コーポレイション |
心血管疾患のための組成物および方法
|
US20140163041A1
(en)
|
2011-02-08 |
2014-06-12 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
|
EP2712315B1
(fr)
|
2011-02-08 |
2021-11-24 |
Oryzon Genomics, S.A. |
Inhibiteurs de lysine déméthylase pour des troubles myéloprolifératifs
|
WO2012116237A2
(fr)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Composés hétérocycliques et leurs utilisations
|
BRPI1101013A2
(pt)
|
2011-03-03 |
2013-06-04 |
Luciano Rabinowicz |
composiÇço para preparo de bebida energÉtica e bebida energÉtica
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
MX347913B
(es)
|
2011-03-25 |
2017-05-17 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Ciclopropilaminas como inhibidores de desmetilasa 1 especifica de lisina.
|
WO2012147890A1
(fr)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
Nouveau dérivé d'azole
|
EP2741741A2
(fr)
|
2011-05-19 |
2014-06-18 |
Oryzon Genomics, S.A. |
Inhibiteurs de la lysine déméthylase destinés au traitement de maladies ou états inflammatoires
|
WO2012156537A2
(fr)
|
2011-05-19 |
2012-11-22 |
Oryzon Genomics, S.A. |
Inhibiteurs de la lysine déméthylase destinés au traitement de la thrombose et de maladies cardiovasculaires
|
EP2524918A1
(fr)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines en tant qu'inhibiteurs de kinase
|
AU2012265842A1
(en)
|
2011-06-07 |
2014-01-23 |
SPAI Group Ltd. |
Compositions and methods for improving stability and extending shelf life of sensitive food additives and food products thereof
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
TW201311149A
(zh)
|
2011-06-24 |
2013-03-16 |
Ishihara Sangyo Kaisha |
有害生物防治劑
|
EP2548877A1
(fr)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
Dérivés de 4-(pyridine condensée à 5 chaînons)benzamide comme inhibiteurs de BTK
|
AP2014007488A0
(en)
|
2011-08-09 |
2014-03-31 |
Takeda Pharmaceutical |
Cyclopropaneamine compound
|
SG2014009609A
(en)
|
2011-08-15 |
2014-05-29 |
Univ Utah Res Found |
Substituted (e)-n'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhiitors
|
WO2013033688A1
(fr)
|
2011-09-01 |
2013-03-07 |
The Brigham And Women's Hospital, Inc. |
Traitement du cancer
|
US9273343B2
(en)
|
2011-09-02 |
2016-03-01 |
Promega Corporation |
Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
|
MA37958B1
(fr)
|
2011-10-10 |
2018-10-31 |
H Lundbeck As |
Pde9i ayant un squelette imidazo pyrazinone
|
CL2014000988A1
(es)
|
2011-10-20 |
2014-11-03 |
Oryzon Genomics Sa |
Compuestos derivados de (aril o heteroaril) ciclopropilamida, inhibidores de lsd1; procedimiento para prepararlos; composicion farmaceutica que los comprende; y metodo para tratar o prevenir cancer, una enfermedad neurologica, una infeccion viral y la reactivacion viral despues de la latencia.
|
US9469597B2
(en)
|
2011-10-20 |
2016-10-18 |
Oryzon Genomics S.A. |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
CN104203914B
(zh)
|
2011-10-20 |
2017-07-11 |
奥瑞泽恩基因组学股份有限公司 |
作为lsd1抑制剂的(杂)芳基环丙胺化合物
|
ITMI20111971A1
(it)
|
2011-10-28 |
2013-04-29 |
Mesogenics Srl |
Inibitori dell'enzima lsd-1 per l'induzione del differenziamento osteogenico
|
US9266881B2
(en)
|
2011-11-14 |
2016-02-23 |
Merck Sharp & Dohme Corp. |
Triazolopyridinone PDE10 inhibitors
|
WO2013085877A1
(fr)
|
2011-12-05 |
2013-06-13 |
Brandeis University |
Traitement de l'amyloïdose au moyen de composés qui régulent la stabilisation de rétromères
|
CA2866450C
(fr)
|
2012-03-07 |
2020-02-18 |
Merck Patent Gmbh |
Derives de triazolopyrazine
|
CN102579381B
(zh)
|
2012-03-30 |
2013-07-10 |
河南中帅医药科技发展有限公司 |
盐酸胍法辛缓释制剂及其制备方法
|
GB201205669D0
(en)
|
2012-03-30 |
2012-05-16 |
Agency Science Tech & Res |
Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof
|
CN103373996A
(zh)
|
2012-04-20 |
2013-10-30 |
山东亨利医药科技有限责任公司 |
作为crth2受体拮抗剂的二并环衍生物
|
ES2710491T3
(es)
|
2012-06-28 |
2019-04-25 |
Novartis Ag |
Moduladores de la vía del complemento y sus usos
|
CN102772444A
(zh)
|
2012-07-06 |
2012-11-14 |
周明千 |
中药超微破壁口服片剂饮片的加工方法
|
GB201212513D0
(en)
|
2012-07-13 |
2012-08-29 |
Ucb Pharma Sa |
Therapeutic agents
|
US9738636B2
(en)
|
2012-09-28 |
2017-08-22 |
Vanderbilt University |
Fused heterocyclic compounds as selective BMP inhibitors
|
SG11201502527UA
(en)
|
2012-10-05 |
2015-04-29 |
Rigel Pharmaceuticals Inc |
Gdf-8 inhibitors
|
CN105051005B
(zh)
|
2012-10-12 |
2017-06-13 |
武田药品工业株式会社 |
环丙胺化合物及其用途
|
EP2919770A4
(fr)
|
2012-11-14 |
2017-03-08 |
The Board of Regents of The University of Texas System |
Inhibition de l'hétérodimérisation de hif-2 avec hif1 (arnt)
|
US9388123B2
(en)
|
2012-11-28 |
2016-07-12 |
Kyoto University |
LSD1-selective inhibitor having lysine structure
|
CA2892375A1
(fr)
|
2012-11-30 |
2014-06-05 |
Darlene E. MCCORD |
Compositions d'hydroxytyrosol et d'oleuropeine pour l'induction de dommages de l'adn, de la mort de cellules et de l'inhibition lsd1
|
EP2740474A1
(fr)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Dérivés de cyclopropylamine utiles comme inhibiteurs d'histone-déméthylases kdm1a
|
US9707275B2
(en)
|
2012-12-19 |
2017-07-18 |
Wockhardt Limited |
Stable aqueous composition comprising human insulin or an analogue or derivative thereof
|
CN103054869A
(zh)
|
2013-01-18 |
2013-04-24 |
郑州大学 |
含***基的氨基二硫代甲酸酯化合物在制备以lsd1为靶标药物中的应用
|
CN103933036B
(zh)
|
2013-01-23 |
2017-10-13 |
中国人民解放军军事医学科学院毒物药物研究所 |
2‑芳基咪唑并[1,2‑α]吡啶‑3‑乙酰胺衍生物在制备防治PTSD的药物中的用途
|
EP2956441A4
(fr)
|
2013-02-18 |
2016-11-02 |
Scripps Research Inst |
Modulateurs des récepteurs de la vasopressine à pouvoir thérapeutique
|
US8558008B2
(en)
|
2013-02-28 |
2013-10-15 |
Dermira, Inc. |
Crystalline glycopyrrolate tosylate
|
WO2014164867A1
(fr)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Inhibiteurs de kdm1a pour le traitement d'une maladie
|
JP2016516399A
(ja)
|
2013-03-13 |
2016-06-09 |
オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション |
非機能性tspo遺伝子を有するトランスジェニック非ヒト生物
|
JP2016517434A
(ja)
|
2013-03-14 |
2016-06-16 |
エピザイム,インコーポレイティド |
癌を処置するための併用療法
|
US20140343118A1
(en)
|
2013-03-14 |
2014-11-20 |
Duke University |
Methods of treatment using arylcyclopropylamine compounds
|
EP3003301B1
(fr)
|
2013-05-30 |
2021-02-24 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
Nouveaux inhibiteurs suicides de la lsd1 ciblant les cellules cancéreuses exprimant le sox2
|
AU2014281398B2
(en)
|
2013-06-19 |
2018-10-04 |
University Of Utah Research Foundation |
Substituted (E)-N'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
|
JP6603213B2
(ja)
|
2013-06-21 |
2019-11-06 |
マイオカーディア,インク |
心臓状態に対するピリミジンジオン化合物
|
US9186391B2
(en)
|
2013-08-29 |
2015-11-17 |
Musc Foundation For Research Development |
Cyclic peptide inhibitors of lysine-specific demethylase 1
|
US9556170B2
(en)
|
2013-08-30 |
2017-01-31 |
University Of Utah Research Foundation |
Substituted-1H-benzo[d]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
EP3043778B1
(fr)
|
2013-09-13 |
2017-09-06 |
Bayer Pharma Aktiengesellschaft |
Compositions pharmaceutiques contenant du refametinib
|
KR101568724B1
(ko)
|
2013-11-13 |
2015-11-12 |
서울대학교산학협력단 |
신규한 화합물, 이의 생산 방법, 및 히스톤 디메틸라제 저해제로서 이의 용도
|
WO2015089192A1
(fr)
|
2013-12-11 |
2015-06-18 |
Quanticel Pharmaceuticals, Inc. |
Inhibiteur de la déméthylase-1 spécifique de la lysine
|
AU2015217064B2
(en)
|
2014-02-12 |
2017-05-04 |
OmniGen Research, L.L.C. |
Composition and method for promoting reduction of heat stress in animals
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
EP3392244A1
(fr)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines en tant qu'inhibiteurs de lsd1
|
AU2015217073B2
(en)
|
2014-02-13 |
2019-08-22 |
Incyte Holdings Corporation |
Cyclopropylamines as LSD1 inhibitors
|
US9346776B2
(en)
|
2014-02-13 |
2016-05-24 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
HUE045725T2
(hu)
|
2014-02-13 |
2020-01-28 |
Incyte Corp |
Ciklopropilaminok mint LSD1 inhibitorok
|
US9428470B2
(en)
|
2014-02-13 |
2016-08-30 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
WO2015145145A1
(fr)
|
2014-03-24 |
2015-10-01 |
Cipla Limited |
Composition pharmaceutique contenant du lapatinib
|
CN103893163B
(zh)
|
2014-03-28 |
2016-02-03 |
中国药科大学 |
2-([1,1′-联苯]-4-基)2-氧代乙基4-((3-氯-4-甲基苯基)氨基)-4-氧代丁酸酯在制备lsd1抑制剂药物中的应用
|
CN106458994B
(zh)
|
2014-04-02 |
2019-09-13 |
百时美施贵宝公司 |
联芳激酶抑制剂
|
EP2929884A1
(fr)
|
2014-04-11 |
2015-10-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Combinaisons pharmaceutiques de dabigatran et antagonistes du récepteur de h2
|
EP2933002A1
(fr)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Compositions pharmaceutiques comprenants de dabigratan et des inhibiteurs de la pompe à protons
|
UY36071A
(es)
|
2014-04-11 |
2015-11-30 |
Takeda Pharmaceutical |
Compuesto de ciclopropanamina y sus usos
|
CN103961340B
(zh)
|
2014-04-30 |
2019-06-25 |
南通中国科学院海洋研究所海洋科学与技术研究发展中心 |
一类lsd1抑制剂及其应用
|
BR112016028219B1
(pt)
|
2014-05-30 |
2022-12-06 |
Istituto Europeo Di Oncologia S.R.L |
Composto ou composição farmacêutica para uso no tratamento ou prevenção do câncer, de uma doença infecciosa, ou de uma doença designada por aberração de metabolismo de energia celular em um indivíduo, processo para obtenção de um composto de fórmula (i) e uso do composto ou composição farmacêutica na fabricação de um medicamento para uso no tratamento ou prevenção do câncer, de uma doença infecciosa, ou de uma doença designada por aberração de metabolismo de energia celular em um indivíduo
|
CN104119280B
(zh)
|
2014-06-27 |
2016-03-16 |
郑州大学 |
含氨基类脲与端炔结构单元的嘧啶衍生物、制备方法及应用
|
WO2016007736A1
(fr)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines en tant qu'inhibiteurs de lsd1
|
WO2016007727A1
(fr)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines et triazolopyrazines utilisables comme inhibiteurs de lsd1
|
WO2016007722A1
(fr)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines et triazolopyrazines utilisables comme inhibiteurs de lsd1
|
TWI687419B
(zh)
|
2014-07-10 |
2020-03-11 |
美商英塞特公司 |
作為lsd1抑制劑之咪唑并吡啶及咪唑并吡嗪
|
GB201417828D0
(en)
|
2014-10-08 |
2014-11-19 |
Cereno Scient Ab |
New methods and compositions
|
CN104173313B
(zh)
|
2014-08-25 |
2017-05-17 |
杭州朱养心药业有限公司 |
利伐沙班片剂药物组合物
|
JP6653116B2
(ja)
|
2014-08-27 |
2020-02-26 |
日本ケミファ株式会社 |
オルメサルタンのプロドラッグ製剤
|
UA122061C2
(uk)
|
2014-10-08 |
2020-09-10 |
Ф. Хоффманн-Ля Рош Аг |
Похідні спіродіаміну як інгібітори альдостеронсинтази
|
TWI714567B
(zh)
|
2015-04-03 |
2021-01-01 |
美商英塞特公司 |
作為lsd1抑制劑之雜環化合物
|
CN107438614B
(zh)
|
2015-04-03 |
2020-01-31 |
拜欧蒂姆公司 |
杂环化合物及它们在预防或治疗细菌感染中的应用
|
CA2981584A1
(fr)
|
2015-04-03 |
2016-10-06 |
Bristol-Myers Squibb Company |
Inhibiteurs de l'indoleamine 2,3-dioxygenase pour le traitement du cancer
|
MY189367A
(en)
|
2015-08-12 |
2022-02-08 |
Incyte Corp |
Salts of an lsd1 inhibitor
|
CN105232488B
(zh)
|
2015-10-15 |
2021-05-04 |
上海凌凯医药科技有限公司 |
一种含有利伐沙班的固体药物组合物
|
KR20180117602A
(ko)
|
2015-12-29 |
2018-10-29 |
미라티 테라퓨틱스, 인크. |
Lsd1 억제제
|
JPWO2017130933A1
(ja)
|
2016-01-25 |
2018-11-29 |
国立大学法人 熊本大学 |
神経変性疾患治療剤
|
EP3445339B1
(fr)
|
2016-04-22 |
2023-08-23 |
Incyte Corporation |
Formulations d'un inhibiteur de lsd1
|
JP2020511424A
(ja)
|
2017-01-18 |
2020-04-16 |
ヴァンダービルト ユニバーシティーVanderbilt University |
選択的bmp阻害としての縮合複素環式化合物
|
CN109963854B
(zh)
|
2017-03-16 |
2022-04-12 |
江苏恒瑞医药股份有限公司 |
杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
|
GEP20237560B
(en)
|
2018-07-05 |
2023-10-25 |
Incyte Corp |
Fused pyrazine derivatives as a2a / a2b inhibitors
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|